Retrospective study of hepatitis c virus relapse after treatment with sofosbuvir and daclatasvir with or without ribavirin

• Main Authors: Mohamed DA Abd Alla (Author), Amer AA Gomaa (Author), Galal A Abou Farrag (Author), Mohamed G Shikhroho (Author), Walid M Mousa (Author), Osama AM Mahmoud (Author)
• Format: Book
• Published: Wolters Kluwer Medknow Publications, 2018-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background and aims The highest prevalence of chronic hepatitis C virus (HCV) genotype 4 infection is reported in Egypt. Fortunately, the oral anti-HCV therapy (OAT) has been available with more than 95% reported 12-week sustained virologic response (SVR) after treatment for 84 days. The current stu...